MD3261661T2 - Menotropină pentru tratarea infertilității - Google Patents

Menotropină pentru tratarea infertilității

Info

Publication number
MD3261661T2
MD3261661T2 MDE20180026T MDE20180026T MD3261661T2 MD 3261661 T2 MD3261661 T2 MD 3261661T2 MD E20180026 T MDE20180026 T MD E20180026T MD E20180026 T MDE20180026 T MD E20180026T MD 3261661 T2 MD3261661 T2 MD 3261661T2
Authority
MD
Moldova
Prior art keywords
menotropin
treating infertility
ovarian stimulation
controlled ovarian
controlled
Prior art date
Application number
MDE20180026T
Other languages
English (en)
Inventor
Saez Joan Carlos Arce
Jane Ruman
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MD3261661T2 publication Critical patent/MD3261661T2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)

Abstract

Prezenta invenţie se referă la o tehnologie de reproducere asistată îmbunătăţită care utilizează menotropină înalt purificată (HP-hMG) pentru a stimula dezvoltarea foliculilor în stimularea ovariană controlată, în special la femeile cu risc de răspuns ovarian ridicat la stimularea ovariană controlată.
MDE20180026T 2015-02-26 2016-02-25 Menotropină pentru tratarea infertilității MD3261661T2 (ro)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562121113P 2015-02-26 2015-02-26
US201562121131P 2015-02-26 2015-02-26
EP15157661 2015-03-04
EP15185191 2015-09-15
PCT/EP2016/053934 WO2016135221A1 (en) 2015-02-26 2016-02-25 Methods of treating infertility

Publications (1)

Publication Number Publication Date
MD3261661T2 true MD3261661T2 (ro) 2024-04-30

Family

ID=56787937

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20180026T MD3261661T2 (ro) 2015-02-26 2016-02-25 Menotropină pentru tratarea infertilității

Country Status (25)

Country Link
US (4) US10413592B2 (ro)
EP (2) EP4289477A3 (ro)
JP (2) JP7163027B2 (ro)
KR (1) KR102618298B1 (ro)
CN (2) CN113769069A (ro)
AU (1) AU2016223496B2 (ro)
CA (1) CA2976032A1 (ro)
DK (1) DK3261661T3 (ro)
ES (1) ES2968102T3 (ro)
FI (1) FI3261661T3 (ro)
HK (1) HK1246655A1 (ro)
HR (1) HRP20240013T1 (ro)
HU (1) HUE064604T2 (ro)
LT (1) LT3261661T (ro)
MA (1) MA41758B1 (ro)
MD (1) MD3261661T2 (ro)
MX (1) MX2017010320A (ro)
PH (1) PH12017501493A1 (ro)
PL (1) PL3261661T3 (ro)
RS (1) RS65096B1 (ro)
RU (1) RU2723098C2 (ro)
SG (1) SG11201706693QA (ro)
SI (1) SI3261661T1 (ro)
WO (1) WO2016135221A1 (ro)
ZA (1) ZA201705489B (ro)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3261661T3 (da) 2015-02-26 2024-01-15 Ferring Bv Menotropin til behandling af infertilitet
JOP20200034A1 (ar) 2017-09-01 2020-02-13 Ferring Bv تركيبة للتنشيط المتحكم فيه للمبيض
CN109602394B (zh) * 2018-12-12 2020-01-17 北京大学第三医院 评估受试者卵巢储备功能的系统
CN110491505B (zh) * 2019-08-22 2021-06-01 北京大学第三医院（北京大学第三临床医学院） 预测受试者卵巢刺激过程中获得的卵母细胞数量的系统
EP3932419A1 (en) * 2020-06-29 2022-01-05 Ferring B.V. Methods of treating infertility
TW202210096A (zh) * 2020-05-29 2022-03-16 荷蘭商菲林公司 治療不育症之方法
KR20230028368A (ko) * 2020-06-26 2023-02-28 훼링 비.브이. 다낭성 난소 증후군 환자의 불임 치료에 사용하기 위한 hp-hmg
KR102498267B1 (ko) 2021-01-13 2023-02-13 주식회사 아이웍스 마이크로버블 생성 혼합 수중 에어레이터 회전분사 조립체

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
JP4574865B2 (ja) 1999-04-16 2010-11-04 インスチチュート マッソーネ エス．エイ． 高度に精製されたゴナドトロピン組成物およびそれらの製造方法
EA009279B1 (ru) * 2001-09-12 2007-12-28 Апплайд Резеч Системз Арс Холдинг Н.В. Применение лютеинизирующего гормона человека, в том числе в сочетании с фолликулостимулирующим гормоном, для содействия имплантации и/или снижения частоты выкидышей
US20140235540A1 (en) 2008-05-20 2014-08-21 Norbert Gleicher Androgen and gonadotropin treatment in females
RU2466724C1 (ru) 2011-05-31 2012-11-20 Фатима Якубовна Богатырева Способ лечения больных бесплодием, обусловленным поликистозом яичников, яичникового генеза на фоне хронического и острого воспаления органов малого таза
US9404908B2 (en) * 2013-04-29 2016-08-02 The Board of Truestees of the Leland Stanford Junior University Non-invasive imaging to the blastocyst stage for the detection of human embryonic aneuploidy
DK3261661T3 (da) 2015-02-26 2024-01-15 Ferring Bv Menotropin til behandling af infertilitet

Also Published As

Publication number Publication date
KR20170123321A (ko) 2017-11-07
LT3261661T (lt) 2024-01-25
WO2016135221A1 (en) 2016-09-01
KR102618298B1 (ko) 2023-12-26
MA41758B1 (fr) 2024-03-29
US20200093893A1 (en) 2020-03-26
HUE064604T2 (hu) 2024-04-28
CN113769069A (zh) 2021-12-10
RU2017131129A3 (ro) 2019-07-17
SG11201706693QA (en) 2017-09-28
JP7163027B2 (ja) 2022-10-31
PL3261661T3 (pl) 2024-03-25
MX2017010320A (es) 2018-01-23
AU2016223496A1 (en) 2017-08-10
FI3261661T3 (fi) 2024-01-15
AU2016223496B2 (en) 2021-09-09
CN107257690A (zh) 2017-10-17
RU2017131129A (ru) 2019-03-28
DK3261661T3 (da) 2024-01-15
HK1246655A1 (zh) 2018-09-14
JP2020203904A (ja) 2020-12-24
RU2723098C2 (ru) 2020-06-08
JP7157108B2 (ja) 2022-10-19
US20210093697A1 (en) 2021-04-01
ZA201705489B (en) 2024-02-28
EP4289477A2 (en) 2023-12-13
EP4289477A3 (en) 2024-02-21
RS65096B1 (sr) 2024-02-29
US20240009278A1 (en) 2024-01-11
US10413592B2 (en) 2019-09-17
JP2018511575A (ja) 2018-04-26
EP3261661A1 (en) 2018-01-03
EP3261661B1 (en) 2023-10-18
MA41758A (fr) 2018-01-03
PH12017501493A1 (en) 2018-01-29
ES2968102T3 (es) 2024-05-07
US20160250296A1 (en) 2016-09-01
CA2976032A1 (en) 2016-09-01
SI3261661T1 (sl) 2024-03-29
US11351228B2 (en) 2022-06-07
US11679145B2 (en) 2023-06-20
HRP20240013T1 (hr) 2024-03-29

Similar Documents

Publication Publication Date Title
MD3261661T2 (ro) Menotropină pentru tratarea infertilității
PH12019500095A1 (en) Compounds, compositions, and methods for the treatment of disease
MX2021008755A (es) Un anticuerpo anti-tau para usarse al tratar una tauopatia.
CL2017001561A1 (es) Formas en estado sólido de pirrolidinonas heteroaromáticas fusionadas
EA201890185A1 (ru) Способы лечения опосредованных гепсидином нарушений
EA201791208A1 (ru) Антитела к cd38 для лечения острого миелолейкоза
EA201691594A1 (ru) Циклопропиламины в качестве ингибиторов lsd1
MX2016011641A (es) Procedimiento de preparacion de proteinas plasmaticas humanas.
CY1124761T1 (el) Ρυθμιστες της δραστικοτητας του συμπληρωματος
BR112016018170A2 (pt) métodos para tratar doença de alzheimer
MX2021008663A (es) Anticuerpos mejorados contra il-6.
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
BR112018003526A2 (pt) métodos de tratamento de doenças inflamatórias
EA201692534A1 (ru) Способы лечения гипотонии
MA46353A (fr) Méthodes de traitement de l'infertilité féminine
NZ744543A (en) Improvements for a gas-powered fixing tool
MY195000A (en) Method for the treatment of neurological disease
MX2019004182A (es) Proceso para la fabricacion de 2,6-dimetil-5-hepten-1-al.
NZ729803A (en) A method for the treatment of motor neuron diseases
MX2017009608A (es) Compuestos anticancerigenos.
EA201792603A1 (ru) Ангиогенез с использованием стимулированных плацентарных стволовых клеток
EA201692246A1 (ru) Способ получения 2,6-диметилбензохинона
CY1125266T1 (el) To rad1901 για χρηση στη θεραπεια του καρκινου των ωοθηκων
MX2017013601A (es) Un proceso de etapas multiples para la produccion de no.
MX2017013156A (es) Metodos para tratar enfermedades.